SOURCE: Solos Endoscopy, Inc.

June 06, 2008 15:00 ET

Solos Endoscopy, Inc. Completes Stock Split and Changes Symbol to SNDY

BOSTON, MA--(Marketwire - June 6, 2008) - Solos Endoscopy, Inc. (PINKSHEETS: SNDY) is pleased to announce that the Company has completed its reverse stock split of 5,000 to 1 and will be operating under the new symbol SNDY. The Solos Endoscopy Board of Directors approved the stock split and capital restructure as a means to position the Company to be more attractive for investors, enhance shareholder value and attract possible acquisition candidates. The capital restructuring will also help to reduce the market volatility that Solos Endoscopy shares have experienced, and to better reflect the Company's earnings as compared to other companies in the medical equipment market.

About Solos Endoscopy, Inc.:

Solos Endoscopy, Inc. is a healthcare technology company whose mission is to develop and market breakthrough technology, applications, medical devices, and procedural techniques for the screening, diagnosis, treatment and management of medical conditions. Backed by technical support, Solos' sales team can help make the right buying decisions for the hospital, surgery center, or physician office. Additional information is available on the Company's website at:

Safe Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.

Contact Information

  • Contact:
    Solos Endoscopy, Inc.